Breast Neoplasms

"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the human BREAST.

Descriptor ID	D001943
MeSH Number(s)	C04.588.180 C17.800.090.500
Concept/Terms	Breast Neoplasms Breast Neoplasms Breast Neoplasm Neoplasm, Breast Breast Tumors Breast Tumor Tumor, Breast Tumors, Breast Neoplasms, Breast Breast Carcinoma Breast Carcinoma Breast Carcinomas Carcinoma, Breast Carcinomas, Breast Mammary Neoplasms, Human Mammary Neoplasms, Human Human Mammary Neoplasm Human Mammary Neoplasms Neoplasm, Human Mammary Neoplasms, Human Mammary Mammary Neoplasm, Human Breast Cancer Breast Cancer Cancer, Breast Mammary Cancer Cancer, Mammary Cancers, Mammary Mammary Cancers Malignant Neoplasm of Breast Breast Malignant Neoplasm Breast Malignant Neoplasms Malignant Tumor of Breast Breast Malignant Tumor Breast Malignant Tumors Cancer of Breast Cancer of the Breast

Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]

Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.

Bar chart showing 882 publications over 31 distinct years, with a maximum of 55 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	4	1	5
1996	6	0	6
1997	1	2	3
1998	5	0	5
1999	9	2	11
2000	6	3	9
2001	7	2	9
2002	14	7	21
2003	12	2	14
2004	22	5	27
2005	25	3	28
2006	21	5	26
2007	34	4	38
2008	15	6	21
2009	29	3	32
2010	30	8	38
2011	31	9	40
2012	36	5	41
2013	33	6	39
2014	38	8	46
2015	49	6	55
2016	31	3	34
2017	40	8	48
2018	36	10	46
2019	34	5	39
2020	36	4	40
2021	30	1	31
2022	43	1	44
2023	36	1	37
2024	24	4	28
2025	20	1	21

Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.

Plichta JK, Bleicher RJ, Boughey J, Margenthaler JA, Mason H, Pesce C, Schulz-Costello K, Sharma R, Sweeting R, Teshome M. Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants' and Program Directors' Preferences Regarding In-Person Versus Virtual Interviews. Ann Surg Oncol. 2025 Oct; 32(11):8514-8522.

View in: PubMed
Van TTV, Tran TH, Nguyen THH, Nguyen VTC, Vo DH, Nguyen GTH, Nguyen TH, To KS, Nguyen AL, Tran CHA, Jasmine TX, Vo TL, Nai THT, Tran TT, Truong MH, Tran NC, Le TL, Nguyen THN, Tu NH, Tran TS, Le BT, Tang VP, Nguyen PTN, Nguyen KT, Ho VC, Nguyen XV, Doan NNT, Tran TT, Tran TMT, Tran VU, Le MP, Vu TL, Tieu BL, Nguyen HTP, Nguyen LHD, Phan NM, Van Phan T, Do TTT, Dao TH, Tang HS, Nguyen DS, Giang H, Phan MD, Nguyen HN, Vo DH, Tran LS. Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals. BMC Biol. 2025 Aug 20; 23(1):259.

View in: PubMed
Karner ER, Wang M, Goel HL, Mercurio AM. GATA3 promotes ferroptosis resistance by repressing integrin ?1 signaling. Proc Natl Acad Sci U S A. 2025 Aug 26; 122(34):e2427304122.

View in: PubMed
Reeves KW, Oulhote Y, Grandjean P, Nielsen F. Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast. Breast Cancer Res. 2025 Aug 18; 27(1):148.

View in: PubMed
Carroll JE, Guard HE, March D, Arcaro KF, Huset C, Balasubramanian R, Kontos D, Sturgeon SR. Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women. Cancer Epidemiol Biomarkers Prev. 2025 Aug 01; 34(8):1306-1313.

View in: PubMed
Reagan AM, Jones VM, Ibrahim-Zada I, Smith SR, Postlewait LM, Farr D, Abelson JS, Cho NL, Foote DC, Meister KM, Montgomery KB, Lindeman B, Kimbrough MK, Nahmias J, Callahan ZM, Marks JA, Sutton JM, Elsaadi A, Burton E, Richmond R, Dodwad SM, Adams SD, Woeste MR, Buonpane CL, Patel P, Anstadt MJ, Nasim BW, Layne D, Jung S, Pratt CG, Quillin RC, Kim J, Patel JA, Cortez AR, Winer LK. Characterizing the General Surgery Experience of Future Breast Surgeons: A Multi-institutional Study from the US ROPE Consortium. Ann Surg Oncol. 2025 Oct; 32(11):8340-8348.

View in: PubMed
Magesh RY, Kaur AN, Keller FN, Frederick A, Tseyang T, Haley JA, Rivera-Nieves AM, Liang AC, Guertin DA, Spinelli JB, Elledge SJ, Watson EV. Aneuploidy generates enhanced nucleotide dependency and sensitivity to metabolic perturbation. Genes Dev. 2025 Jun 02; 39(11-12):770-786.

View in: PubMed
Roy R, Schunkert EM, Olivova P, Gilar M, Geromanos S, Li GZ, Gebler J, Dagher A, El-Hayek A, Aldakhlallah R, Staffa SJ, Zurakowski D, Lotz M, Pories S, Moses MA. Identification of vitronectin as a potential non-invasive biomarker of metastatic breast cancer using a label-free LC-MS/MS approach. Breast Cancer Res. 2025 May 29; 27(1):94.

View in: PubMed
Freitas AJA, Causin RL, Calfa S, Santana IVV, Balie M, Hirai W, Laus AC, Araujo HS, Hidalgo Filho CM, de Oliveira Bombarda F, da Silva VD, Evangelista AF, de P?dua Souza C, Reis RM, Marques MMC. Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. Breast Cancer Res Treat. 2025 Jul; 212(2):237-250.

View in: PubMed
Huong GN, Nguyen HL, Goldberg RJ, Epstein MM, Allison JJ, Pham LQ, Giang LM, Nguyen SM, Nguyen ND, Nguyen LTT, Van QL, Van TT, Huong TT. Thirty-Year Trends (1991-2020) in Breast Cancer Incidence Rates: Hanoi, Vietnam. JCO Glob Oncol. 2025 May; 11:e2400570.

View in: PubMed

People

Explore

Similar Concepts

Top Journals